Method for Evaluating Neuromodulatory Properties of Dental Pulp Stem Cell as an In Vitro Model for Parkinson’s Disease

2019 ◽  
pp. 193-196
Author(s):  
Nareshwaran Gnanasegaran ◽  
Deepak B. Thimiri Govinda Raj ◽  
Sivakumar Arumugam
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Stem Cell ◽  
Dental Pulp ◽  
In Vitro Model ◽  
Dental Pulp Stem Cell ◽  
Vitro Model

scholarly journals Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson’s disease

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Alysia Ross ◽  
Viktoria Xing ◽  
Ting Ting Wang ◽  
Samantha C. Bureau ◽  
Giovana A. Link ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
In Vitro Model ◽  
Membrane Depolarization ◽  
Vitro Model

scholarly journals Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease

2014 ◽  
Vol 8 (3) ◽  
pp. 943-950 ◽  
Author(s):  
LEI LU ◽  
LE TANG ◽  
WENSHI WEI ◽  
YUNYI HONG ◽  
HEYU CHEN ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Survival Rate ◽  
In Vitro Model ◽  
Nicotinamide Mononucleotide ◽  
Vitro Model

Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway

Fitoterapia ◽  
2020 ◽  
Vol 143 ◽  
pp. 104553 ◽  
Author(s):  
Agnese Gugliandolo ◽  
Federica Pollastro ◽  
Placido Bramanti ◽  
Emanuela Mazzon
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
In Vitro Model ◽  
Mtor Pathway ◽  
Protective Effects ◽  
Vitro Model

Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease

2013 ◽  
Vol 25 (12) ◽  
pp. 2863-2870 ◽  
Author(s):  
Tao Chen ◽  
Yue-fan Yang ◽  
Peng Luo ◽  
Wei Liu ◽  
Shu-hui Dai ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Calcium Homeostasis ◽  
In Vitro Model ◽  
Dopamine Neurons ◽  
Vitro Model

Development of ATP13A2-deficient in vitro Model for PARK9 Parkinson’s Disease

2021 ◽  
Vol 16 ◽  
Author(s):  
Yiing Jye Yap ◽  
Ezharul Hoque Chowdhury ◽  
Rhun Yian Koh ◽  
Soi Moi Chye ◽  
Kenny Gah Leong Voon ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Western Blot ◽  
Calcium Chloride ◽  
In Vitro Model ◽  
Alpha Synuclein ◽  
Fluorescence Signal ◽  
Carbonate Apatite ◽  
Vitro Model

Background: PARK9 familial Parkinson’s disease (PD) is caused by loss-of-function mutation in ATP13A2 gene in which the mutation impairs autophagic-lysosomal degradation pathway and induces intraneuronal accumulation of alpha-synuclein. RNA interference has been a useful tool to generate in vitro knockdown model to study the physiological role of gene. However, availability of validated ATP13A2-deficient in vitro model is limited. Objective: Hence, we developed the ATP13A2-deficient PD model by delivering ATP13A2 siRNA into neuroblastoma cells using carbonate apatite nanoparticles (CA NPs). Method: CA NPs were fabricated using different concentrations of calcium chloride and characterised, in the presence or absence of ATP13A2 siRNA. Time-dependent stabilities of CA NPs and CA NPs-associated siRNA (CA-siRNA) complex were evaluated by pH, turbidity, size, and zeta potential measurements. The dissolution abilities at acidic condition of both complexes were investigated. Following that, green fluorescence protein (GFP) and four different siRNAs targeting ATP13A2 (siRNA_5, 6, 7 and 8) were transfected to cells with the fabricated CA NPs. Western blot was performed to determine the knockdown effect of the four siRNAs. Results: It was found that 4 mM calcium chloride was ideal for CA NP formation while incubation time of 48 hours is required to maintain the stability of nanoparticles. Successful transfection was confirmed by detection of fluorescence signal from the GFP plasmid and subsequent silencing of this signal by transfecting GFP siRNA. Western blot analysis revealed that ATP13A2 protein expression was significantly reduced to 20% upon transfection with 20 nM of siRNA_5. Conclusion: ATP13A2-deficient PD model was successfully developed.

Sign in / Sign up

Export Citation Format

Share Document